Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. ALPHAGAN P OPHTHALMIC SOLUTION 0.15% W/V [SIN12336P]

ALPHAGAN P OPHTHALMIC SOLUTION 0.15% W/V [SIN12336P]

Active ingredients: ALPHAGAN P OPHTHALMIC SOLUTION 0.15% W/V

Last updated 26 October 2025

Product Info

ALPHAGAN P OPHTHALMIC SOLUTION 0.15% W/V

[SIN12336P]

Product information

Active Ingredient and Strength

BRIMONIDINE TARTRATE - 0.15% W/V

Dosage Form

SOLUTION

Manufacturer and Country

ALLERGAN SALES LLC - UNITED STATES

Registration Number

SIN12336P

Licence Holder

ABBVIE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

S01EA05

INDICATIONS AND USAGE
ALPHAGAN® P is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

DOSAGE AND ADMINISTRATION
The recommended dose is one drop of ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% in the affected eye(s) three times daily, approximately 8 hours apart.
If more than one topical ophthalmic drug is to be used, the different drugs should be instilled at least 5 minutes apart.

CONTRAINDICATIONS
ALPHAGAN® P is contraindicated in patients with hypersensitivity to brimonidine tartrate or any component of this medication. It is also contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy and contraindicated in neonates and infants (children under the age of 2 years).